AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| NZK | Ann: NZK ongoing disclosure - Grant Rosewarne | 18/04/18 | 0 | 41 | |||
|
|||||||
| NZK | Ann: NZK - Best Aquaculture Practices 4 star certification | 10/04/18 | 0 | 32 | |||
|
|||||||
| NZK | Ann: SPH Notice - New Zealand Superannuation Fund Nominees Ltd | 05/04/18 | 0 | 47 | |||
|
|||||||
| NZK | Ann: NZK FY18 Interim Report | 28/03/18 | 0 | 50 | |||
|
|||||||
| NZK | Ann: NZK - appointment of alternate director | 28/03/18 | 0 | 36 | |||
|
|||||||
| NZK | Ann: NZK ongoing disclosure - Grant Rosewarne - amended | 26/03/18 | 0 | 29 | |||
|
|||||||
| NZK | Ann: NZK ongoing disclosure - Grant Rosewarne | 23/03/18 | 0 | 51 | |||
|
|||||||
| NZK | Ann: NZK 1H18 ASX Appendix 3A.1 Interim Div notice with final FX | 23/03/18 | 0 | 36 | |||
|
|||||||
See All Discussions
NZX News